- Home
- CNK vs HCM Comparison
CNK vs HCM Comparison
Compare CNK & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNK | HCM |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.7B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNK | HCM |
|---|---|---|
| Price | $26.88 | $14.67 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 10 | 1 |
| Target Price | ★ $32.90 | $13.75 |
| AVG Volume (30 Days) | ★ 2.4M | 22.1K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $3,115,000,000.00 | N/A |
| Revenue This Year | $10.59 | N/A |
| Revenue Next Year | $3.83 | $16.12 |
| P/E Ratio | $25.00 | ★ $5.49 |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $21.60 | $11.51 |
| 52 Week High | $34.01 | $19.50 |
Technical Indicators
Market Signals| Indicator | CNK | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 63.60 | 45.32 |
| Support Level | $24.84 | $14.15 |
| Resistance Level | $27.45 | $15.61 |
| Average True Range (ATR) | 1.03 | 0.42 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 79.39 | 33.33 |
Price Performance
Historical ComparisonAbout CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.